The proposed research will measure the relative reinforcing value of two separate dimensions of cigarette smoke -- the sensory components (taste, aroma and tracheo-bronchial stimulation), and the pharmacologic actions of nicotine. These components of reinforcement will be dissociated with methods developed in the previous period of grant support. In one method, the sensory effects of cigarette smoke are presented with very little nicotine absorption by restricting inhaled smoke to the large, upper airways, where few smoke particles are deposited. Conversely, the pharmacologic effects can be presented with little sensory impact by greatly diluting the smoke prior to deep inhalations of large volumes. A method for eliciting the tracheo-bronchial """"""""scratch"""""""" of smoke without any nicotine consists of delivering puffs of a fine aerosol containing a mildly irriating solution of citric acid. The subjective satisfaction and reduction in smoking behavior will be assessed after inhalations of the types just described. Changes in nicotine preference will be measured by allowing subjects to vary the nicotine concentration in each puff of smoke. Subjects' preference for the sensory versus pharmacologic components of smoke will also be studied after different satiation procedures. The hypothesis that sensory reinforcement arises from the association of stimuli with nicotine reinforcement will be tested by examining extinction after many nonreinforced presentations. The importance of temporal continguity in maintaining the conditioned reinforcing value of cigarette smoke will be evaluated by varying the time interval between sensory stimulation and nicotine reinforcement. The knowledge gained from this research may lead to more effective methods for reducing the incidence of cigarete smoking and related cardiovascular and pulmonary diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA002665-08
Application #
3207498
Study Section
Drug Abuse Clinical and Behavioral Research Review Committee (DACB)
Project Start
1981-09-30
Project End
1989-02-28
Budget Start
1988-09-01
Budget End
1989-02-28
Support Year
8
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Rose, Jed E; Salley, Al; Behm, Frederique M et al. (2010) Reinforcing effects of nicotine and non-nicotine components of cigarette smoke. Psychopharmacology (Berl) 210:1-12
Rose, Jed E; Behm, Frederique M; Westman, Eric C et al. (2006) Precessation treatment with nicotine skin patch facilitates smoking cessation. Nicotine Tob Res 8:89-101
Rose, Jed E; Behm, Frederique M (2004) Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments. Nicotine Tob Res 6:523-32
Rose, Jed E; Behm, Frederique M; Westman, Eric C et al. (2003) Pharmacologic and sensorimotor components of satiation in cigarette smoking. Pharmacol Biochem Behav 76:243-50
Rose, Jed E; Behm, Frederique M; Westman, Eric C et al. (2003) Mecamylamine acutely increases human intravenous nicotine self-administration. Pharmacol Biochem Behav 76:307-13
Rose, J E; Behm, F M; Westman, E C (2001) Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking. Pharmacol Biochem Behav 68:187-97
Rose, J E; Behm, F M; Westman, E C et al. (2000) Dissociating nicotine and nonnicotine components of cigarette smoking. Pharmacol Biochem Behav 67:71-81
Rose, J E; Behm, F M; Westman, E C et al. (1999) Arterial nicotine kinetics during cigarette smoking and intravenous nicotine administration: implications for addiction. Drug Alcohol Depend 56:99-107
Rose, J E; Westman, E C; Behm, F M et al. (1999) Blockade of smoking satisfaction using the peripheral nicotinic antagonist trimethaphan. Pharmacol Biochem Behav 62:165-72
Rose, J E; Corrigall, W A (1997) Nicotine self-administration in animals and humans: similarities and differences. Psychopharmacology (Berl) 130:28-40

Showing the most recent 10 out of 37 publications